Navigation Links
Engineered microbes grow in the dark
Date:5/19/2013

Scientists at the University of California, Davis have engineered a strain of photosynthetic cyanobacteria to grow without the need for light. They report their findings today at the 113th General Meeting of the American Society for Microbiology.

"In this work, we used synthetic biology approaches to probe and rewire photoautotrophic (exclusively relying on carbon dioxide and light energy for growth) cyanobacterial metabolism for the ability to grow without light energy," says Jordan McEwen, the lead researcher on the study. He is part of Shota Atsumi's lab at the university, a research group focused on developing synthetic organisms capable of converting carbon dioxide directly to biofuels.

The cyanobacterium strain Synechococcus elongatus strain PCC 7942 has been well characterized as a model photoautotroph. Previous work by Atsumi's lab has engineered this organism to recycle carbon dioxide into a variety of biofuels and valuable chemicals in the presence of light. Any cost-effective, cyanobacterial biofuel production scheme would use natural lighting conditions, limiting how much biofuel could be produced in a 24-hour period.

"To overcome this constraint, we installed foreign genes into S. elongatus to allow this cyanobacterium to grow and generate biofuels in diurnal (light or dark) conditions," says McEwen. "With recent, increased focus on cyanobacteria-based industrial applications, this advancement is desirable for more efficient, economical and controllable bioproduction systems."


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. Europe needs genetically engineered crops, scientists say
2. Recruiting engineered cells to work for warfighters
3. Market Analysis: Biomaterials and Engineered Protein
4. Painting with catalysts: Nano-engineered materials for detoxifying water by use of sunlight
5. Engineered bacteria make fuel from sunlight
6. Production of 5-aminovaleric and glutaric acid by metabolically engineered microorganism
7. Engineered immune cells produce complete response in child with an aggressive pediatric leukemia
8. Leukemia patients remain in remission more than 2 years after engineered T cell therapy
9. Bioengineered marine algae expands environments where biofuels can be produced
10. Soft Robotics: A groundbreaking new journal on engineered soft devices that Interact with Living Systems
11. Engineered bacteria can make the ultimate sacrifice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017 MedNet ... that supports the entire spectrum of clinical research, ... another record-breaking year for the organization in terms ... in MedNet,s eClinical products and services. The company,s ... marketplace success of iMedNet ...
(Date:1/12/2017)... , January 12, 2017 A new report by Allied Market ... the global biometric technology market is expected to generate revenue of $10.72 billion by ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/6/2017)... Jan. 5, 2017  SomaLogic announced today that ... Alliance" established by iCarbonX, the China ... a "Global Digital Health Ecosystem that can define ... of individual,s biological, behavioral and psychological data, the ... the companies, SomaLogic will provide proteomics data and ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... Executive ... 2017 in its continued commitment to the advancement of the clinical trials segment. ... issues related to clinical trial planning and management. , As executive talent ...
(Date:1/18/2017)... FL (PRWEB) , ... January 18, 2017 , ... ... weakness and paralysis, today announced that it has submitted a 510(k) to the ... bikes that utilize MYOLYN’s patent-pending functional electrical stimulation (FES) technology. , The ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... the latest paper by its Science Editor, Dr. Elisabeth Bik, in the December ... Microbiologie). Dr. Bik joined uBiome in October 2016 from her previous position at ...
(Date:1/18/2017)... 18, 2017  Caris Life Sciences, a leading ... the largest private funder of pancreatic cancer research, ... the impact of immunotherapy in the treatment of ... services to identify potential trial candidates based on ... physicians and study investigators. The Lustgarten Foundation is ...
Breaking Biology Technology: